Fibromyalgia: A Review of Current Knowledge

1992 ◽  
Vol 10 (1) ◽  
pp. 13-17 ◽  
Author(s):  
Peter Baldry

Muscular pain in the presence of a normal ESR has laboured under a variety of names and supposed causes, often being dismissed as psychogenic in origin. It is now clear that there are two specific disorders of body musculature, each with its own defined pattern of symptoms. Fibromyalgia is a disease of unknown aetiology, predominantly affecting women, that gives generalised muscular pain, a disturbed sleep pattern, morning stiffness and fatigue. Tender spots are found at certain charecteristic sites. The Myofascial Pain Syndromes, on the other hand, can usually be related to some form of trauma and are normally localised to particular muscles with readily palpable myofascial trigger points at specific spots according to the pattern of pain referral. Acupuncture may be a rapid and effective treatment for both disorders, often giving long lasting relief in Myofascial Pain Syndromes, but offering only repeated short term responses to Fibromyalgia sufferers.

2006 ◽  
Vol 21 (2) ◽  
pp. 91-91
Author(s):  
Marc Brodsky

The Arts Medicine Master Class case discussion on Myofascial Pain in a Guitarist (MPPA December 2005) reinforced some of the take-home points from an earlier article entitled An Innovative Patient-centered Approach to Common Playing-related Pain Conditions in Musicians (MPPA December 2004)2 and the more recent abstract presentation and workshop at the 2005 Aspen Conference: 1) myofascial trigger points are a common component of pain syndromes; 2) the short-term solution to myofascial pain is addressing trigger points, and the longterm solution is managing potentiators of pain (practice habits, posture, ligament laxity, psychological stress, etc.); and 3) self-care can contribute to the short-term and long-term solutions to myofascial pain.


2018 ◽  
Vol 38 (06) ◽  
pp. 640-643 ◽  
Author(s):  
Douglas Comeau ◽  
James Otis ◽  
Jason Weller

AbstractMyofascial pain syndromes arise from acute and chronic musculoskeletal pain and often have a referred neuropathic component. It affects more than three quarters of the world's population and is one of the most important and overlooked causes of disability. The origins of pain are thought to reside anywhere between the motor end plate and the fibrous outer covering of the muscle, with involvement of microvasculature and neurotransmitters at the cellular level. Diagnosis is made by clinical examination for the presence of myofascial trigger points, though some ancillary tests may provide supportive evidence. The mainstay of treatment is regular physical therapy with the goal of restoration of normal muscle laxity and range of motion. Adjunct therapies including pharmacologic and nonpharmacologic interventions provide varying degrees of benefit in refractory cases, and onabotulinum toxin A injection has the most evidence of efficacy for these patients. Here, we discuss the epidemiology, pathophysiology, and diagnostic and therapeutic options for the evaluation and treatment of myofascial pain syndrome.


2019 ◽  
pp. 105-109
Author(s):  
Gaurav Chauhan

The Sternocleidomastoid (SCM) muscle may develop myofascial trigger points and the physical manifestation of pain and signs and symptoms due to these trigger points is commonly referred to as SCM syndrome. The diagnosis of SCM syndrome can be onerous as non-specific signs and symptoms associated with SCM syndrome may vary in presentation. The subject in this case report had post-acceleration-deceleration induced injury to SCM with hypertrophy of sternocleidomastoid muscle on the left side. The patient reported pain over the left SCM muscle, forehead, around the ipsilateral eye, over the cheek, the tip of the chin, sternoclavicular joint and deep in the throat upon. The patient was ascribed various diagnosis before a definitive diagnosis was made. The patient underwent three trigger point injections under ultrasound guidance, last one with BOTOX, and reported long-lasting pain relief. Overall with intensive physical therapy and trigger point injections the acute symptoms resolved. Key words: Sternocleidomastoid syndrome, myofascial pain syndromes, trigger points, ultrasound, Botox


2007 ◽  
Vol 15 (2) ◽  
pp. 69-84 ◽  
Author(s):  
David G. Simons ◽  
Jan Dommemolt

2020 ◽  
Vol 2 (1) ◽  
pp. 66-70
Author(s):  
O. V. Shimarova ◽  
V. V. Malakhovskiy ◽  
V. G. Zilov

Myofascial pain syndromes are a widespread pathology, which is a condition that is characterized by local muscle stiffness and the formation of trigger points in them. The pathophysiology of myofascial pain syndromes is not fully understood. Studies indicate the role of dysfunction of the end plate of the muscle, impaired proprioreception and sensomotor control, central sensitization. The review presents a modern view of approaches to the treatment of myofasial pain syndrome of the neck region, based on an understanding of its pathophysiology.


2005 ◽  
Vol 13 (4) ◽  
pp. 39-48 ◽  
Author(s):  
David G. Simons ◽  
Jan Dommerholt

Sign in / Sign up

Export Citation Format

Share Document